Recombinant immune complexes as versatile and potent vaccines.

Area of Science:

• Vaccinology
• Protein Engineering
• Plant Biotechnology

Background:

• Immune complexes (IC) can enhance immune responses compared to antigens alone.
• Manufacturing challenges limit the clinical application of traditional IC vaccines.

Purpose of the Study:

• To develop a novel manufacturing platform for immune complexes (IC) as vaccines.
• To overcome production difficulties associated with traditional IC vaccine formulations.

Main Methods:

• Engineered recombinant IC (RIC) by expressing immunoglobulin and antigen as a fusion protein.
• Utilized a modular RIC system for adaptable antigen gene insertion.
• Employed plant-based expression systems for RIC production.

Main Results:

• Demonstrated successful production of RIC via coordinate expression in plants.
• The modular RIC system allows for broad applicability across various antigens.
• Plant-based manufacturing offers a scalable and potentially cost-effective approach.

Conclusions:

• Plant-expressed RIC represent a viable and broadly applicable vaccine manufacturing platform.
• This approach addresses key manufacturing hurdles for IC-based vaccines.
• RIC technology holds promise for advancing vaccine development.